Declining ALS Patients Are Waiting On The FDA...

Max Richter is one of the most successful classical composers alive. His catalog has had more than 4 billion streams and his works range from an eight-hour album based on the science of sleep to the Oscar-nominated score for the film Hamnet. Richter’s work often responds to polit ...  Show more

Wall Street’s brutal, $3.7 trillion rout cascaded into Asian markets, putting chipmakers and tech companies in its crosshairs. Host K. Oanh Ha sat down with Bloomberg Opinion Columnist Shuli Ren to look at what comes next for AI – and consider whether this is simply a correction ...  Show more

ALS is a fatal neurological disease that kills motor neurons. Even though it was first described more than 150 years ago, there is no cure, and the few drugs available only dampen the symptoms or slow the progression by a few months. In recent years new drugs have emerged. How ...

ALS is a disease that destroys the nerve cells in the brain and spinal cord we need for voluntary movement. There is no cure, but now there is a newly approved medication that may slow down the disease and extend patients' lives. The drug, called Relyvrio, got its start with a co ...  Show more

When the F.D.A. approved the drug Aduhelm, the first Alzheimer’s treatment to receive the agency’s endorsement in almost two decades, it gave hope to many.

But the decision was contentious; some experts say there’s not enough evidence that the treatment can address cogni ...